Market Place
Sourcing Support
SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks
05 Apr 2022 //
BUSINESSWIRE
SanBio: Notice Regarding Completion of Approval Filing for Japan SB623
07 Mar 2022 //
BUSINESSWIRE
SanBio Announces Publication Comparing Outcome Measures
01 Nov 2021 //
BUSINESSWIRE
SanBio Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623
04 Jan 2021 //
BUSINESSWIRE
Additional Analytical Results of the Phase 2 Trial of Regenerative Cell Medicine
13 Sep 2020 //
BUSINESSWIRE
SanBio to Announce the Results of a Phase 2 STEMTRA Tria SB623
07 Mar 2019 //
BUSINESSWIRE
SanBio: Notice Regarding an Equity and Business Alliance Between Five Companies
22 Sep 2018 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.